Swiss HLG President chairing panel 'AI Transforming BioPharma Panel: Beyond the Hype', September 25th, 2024

Home » Swiss HLG President chairing panel 'AI Transforming BioPharma Panel: Beyond the Hype', September 25th, 2024

Discover the Real Impact of AI in Biopharma! Join us for the 'AI Transforming BioPharma Panel: Beyond the Hype' at the hashtag#Sachs_BEF on September 25th, 2024, at the Mövenpick Hotel Basel. Explore the genuine advancements and practical applications of artificial intelligence that are revolutionizing biopharmaceuticals.

Chaired by:
Sarah Holland, President of Swiss HLG & CBO, Cureteq AG - a Partex Company
Panellists:
Frank Grams, Chief Commercial Officer, Partex N.V.
Katharina Kreymborg, SVP (CSO Partner Team), Curie.Bio
Parker Moss, EVP Corporate Development, Exscientia Ltd.
Patrick Schwab, Senior Director, AI & Machine Learning, GSK
Ricardo Gaminha Pacheco, Strategic Partnering, Business Development & Licensing Director, Insilico Medicine

This panel will cut through the noise to examine how AI technologies are truly transforming drug discovery, development, and market strategies. Engage with industry experts as they discuss overcoming challenges, achieving breakthroughs, and forecasting the future of AI in biopharma.

Don’t miss this opportunity to gain in-depth insights and network with pioneers in the field. Secure your spot today at www.sachsforum.com/24bef and join us, both hashtag#InPerson & hashtag#Online, during the Sachs Autumn Life Sciences Week.

21 July 2024
·

SUBSCRIBE TO OUR NEWSLETTER

Keep up to date with the latest information by signing up to Swiss HLG newsletter!
Sign up now !

2023 © Swiss HLG | by evago.fr

Cookies settings

linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram